Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 17 Mar 2026 for Bioventus Inc.. Read the official filing
Filing timeline
BuySaleRobert E. Claypoole
Insider track record
Disclosed buys
0
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+28.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Robert E. Claypoole: trading record in brief
This profile gathers the share dealings of Robert E. Claypoole in Bioventus Inc. The record holds 5 filings, for trades running from 10 January 2025 to 13 March 2026.
The open-market record consists of 1 sale worth €256k, with no purchase. Other entries cover 1 share grant and 3 option exercises.
The newest entry dates from 17 March 2026: an option exercise, in Bioventus Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert E. Claypoole
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
33,500 shares0Class A Common StockSEC:0002005474-26-000004:0
93,750 shares0Class A Common StockSEC:0002005474-26-000002:0
41,717 shares@ US$8.0352.9% of flowClass A Common StockSEC:0002005474-26-000002:1
28,786 shares@ US$9.1047.1% of flowClass A Common StockSEC:0001578563-25-000023:0
93,750 shares0Class A Common StockSEC:0001578563-25-000015:0
5 of 5 declarations
